FDA Regulatory Friday, June 12, 2026 +0.85 Positive

FDA Clears First OTC Continuous Glucose Monitor for Children

The FDA approved Dexcom Inc.'s Stelo Glucose Biosensor System, the first over-the-counter continuous glucose monitor for children ages 2 and older who don't use insulin. The integrated CGM device can now be marketed directly to consumers without prescription.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day